Guardant Health
Guardant Health raises $360M Series E at $2.15B valuation
Quick Facts
Guardant Health: Series E Funding Round
Guardant Health has successfully raised $360M in Series E funding, reaching a valuation of $2.15B.
Company Overview
Blood-based cancer detection and monitoring
Funding Details
The Series E round was led by SoftBank Vision Fund, with participation from OrbiMed.
Company Information
- Headquarters: Redwood City, CA
- Founded: 2012
- Employees: 1000+
- Category: Biotech
Investment
Guardant Health plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- SoftBank Vision Fund: Verified investor in Series E
- OrbiMed: Verified investor in Series E
Key Investors
About the Author
Related Company Reports
Arthrosi Therapeutics raises $153M Series E at $800M valuation
Arthrosi Therapeutics raises $153M in Series E at $800M valuation. Developing next-generation gout treatment drug for chronic conditions...
HorizonStudio Raises $100M Growth to Transform Biotech
HorizonStudio has secured $100M Growth in funding to accelerate growth and innovation. Leading artificial intelligence infrastructure enabling scalable ML deployment for businesses...
StreamData Raises $15M Seed to Transform Biotech
StreamData has secured $15M Seed in funding to accelerate growth and innovation. Leading artificial intelligence infrastructure enabling scalable ML deployment for businesses...
